One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

LMB contribution towards UK bioscience success illuminated

Published on 25 June, 2015

The stories behind three great LMB successes are highlighted in a report by the UK BioIndustry Association (BIA). Humira, the first fully humanised antibody and one of the worlds top selling drugs (pages 3-4), Lemtrada (CAMPATH) treatment for Multiple Sclerosis (pages 5-6) and the Stabilised GPCR StaR® technology which enables determination of receptor structures (pages 11-12) all came from work carried out at the LMB. To read about these stories and others, please download the pdf “Celebrating UK Bioscience“.